Lam Research Corporation $LRCX Position Boosted by Spire Wealth Management

Spire Wealth Management increased its position in Lam Research Corporation (NASDAQ:LRCX) by 19.2% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 25,292 shares of the semiconductor company’s stock after purchasing an additional 4,073 shares during the period. Spire Wealth Management’s holdings in Lam Research were worth $3,387,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. IMG Wealth Management Inc. acquired a new position in shares of Lam Research in the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research during the 2nd quarter valued at approximately $27,000. Sound Income Strategies LLC bought a new position in Lam Research during the third quarter worth $41,000. Tripletail Wealth Management LLC bought a new position in Lam Research during the third quarter worth $44,000. Finally, Strategic Wealth Investment Group LLC acquired a new position in Lam Research in the second quarter worth $29,000. 84.61% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the sale, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares of the company’s stock, valued at $264,303.48. The trade was a 44.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 102,608 shares of company stock valued at $14,916,496 over the last three months. 0.31% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on LRCX. B. Riley increased their target price on shares of Lam Research from $180.00 to $195.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Jefferies Financial Group reaffirmed a “buy” rating and set a $200.00 price objective (up previously from $175.00) on shares of Lam Research in a research report on Monday, December 15th. Cowen reiterated a “buy” rating on shares of Lam Research in a research note on Thursday, October 23rd. Wells Fargo & Company raised their target price on shares of Lam Research from $135.00 to $145.00 and gave the stock an “equal weight” rating in a report on Thursday, October 23rd. Finally, Sanford C. Bernstein upped their target price on Lam Research from $170.00 to $175.00 and gave the company an “outperform” rating in a report on Friday, November 21st. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $163.04.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Multiple analysts and research notes are highlighting Lam’s exposure to AI chipmaking tools, helping drive the recent multi-day rally and raising investor appetite. Lam Research Is Up 19.1% After Analysts Spotlight Its AI-Focused Chipmaking Tools
• Positive Sentiment: Comparative analyst coverage gives Lam an edge versus peers (e.g., TSM), citing steadier growth and stronger positioning in the AI equipment cycle. LRCX vs. TSM: Which Semiconductor Powerhouse Is the Better Buy?
• Positive Sentiment: High-profile endorsements and buy ratings (including visible media mentions) have amplified investor interest and momentum. Jim Cramer notes that Lam Research is one of the stocks he likes so much
• Neutral Sentiment: Lam set a public date for its December-quarter earnings conference call on Jan. 28 — a key event that should clarify near-term demand and margins. Lam Research Corporation Announces December Quarter Financial Conference Call
• Neutral Sentiment: Some firms updated or reissued ratings (Aletheia Capital noted a new rating), which can change short-term flows but didn’t by itself set a clear positive/negative bias. Lam Research Receives a New Rating from Aletheia Capital
• Negative Sentiment: Significant insider selling has been reported (multiple executives sold shares), which may raise governance or timing concerns for some investors. Lam Research Stock Opinions on Recent ‘Buy’ Rating and AI Demand
• Negative Sentiment: Analysts and commentators warn about valuation risk after the steep run-up — rapid gains can lead to sharp pullbacks if macro or demand signals soften. As Lam Research Surges, Here Is The Risk You Should Know
• Negative Sentiment: The stock has shown short-term volatility and recently dipped more than the broader market on profit-taking and rotation. Why Lam Research (LRCX) Dipped More Than Broader Market Today

Lam Research Price Performance

NASDAQ LRCX opened at $200.96 on Friday. The company has a 50-day moving average price of $164.77 and a two-hundred day moving average price of $131.92. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $210.45. The stock has a market cap of $252.41 billion, a price-to-earnings ratio of 44.26, a price-to-earnings-growth ratio of 2.34 and a beta of 1.77. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the previous year, the firm posted $0.86 earnings per share. The business’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were paid a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. Lam Research’s dividend payout ratio is presently 22.91%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.